Epil'O — Anti-Regrowth Treatment Limoncello Weekend in Rome 50ml

LARREA DIVARICATA EXTRACT is the anti-regrowth active ingredient in the formula, dosed at 3% according to the manufacturer's communication. This extract from the desert plant (creosote bush) contains NDGA (nordihydroguaiaretic acid), an antioxidant polyphenol whose action on certain follicular growth enzymes is documented in cosmetic literature. The mention "dermatologically tested" on the packaging refers to a skin tolerance test and not a clinical demonstration of anti-regrowth efficacy — these are two distinct levels of proof not to be confused in Paradermia communications. Important pharmacological point: chaparral/Larrea divaricata is known to cause toxic hepatitis via ORAL administration (FDA warning since 1992) — hence the importance of the "do not swallow" warning on this readily accessible pump bottle. Topically, systemic absorption remains limited and tolerance is documented at 3%. This Limoncello variant is structurally different from the other two scents (Cherry and Mango) in the Epil'O anti-regrowth series. It contains SIX EU declarable allergens: FARNESOL, BENZYL BENZOATE, CITRAL, LINALOOL, LIMONENE, and GERANYL ACETATE. This is the most heavily loaded profile of the brand. Major photosensitizing risk with this variant. Three photosensitizing essential oils are present: CITRUS AURANTIUM BERGAMIA PEEL OIL (bergamot, furanocoumarins including bergapten), CITRUS AURANTIUM PEEL OIL (bitter orange, low doses of bergapten), and EUCALYPTUS GLOBULUS OIL. For a product applied daily to areas regularly exposed to the sun, the risk of cumulative photodermatitis during the summer is real — especially since the area has just been epilated. The minimalist instruction "avoid sun exposure for 2 hours" commonly seen on this type of product is insufficient: for daily leave-on use, extend to the entire day during summer (April-October) and prioritize evening application. CAMPHOR warrants a contraindication during pregnancy and breastfeeding, even at low topical concentrations. Camphor is a potential neurotoxin in the fetus and infant, and standard pharmaceutical practice contraindicates its topical use from conception. This contraindication is firm — without reservation for "recommended doses." SODIUM METABISULFITE is present as an antioxidant: very rare topical cross-reaction with dietary sulfite sensitivity, to be noted for affected individuals. For individuals who are not pregnant, have no known photosensitivity, no planned sun exposure, and tolerate complex fragrances, this variant remains usable. All other individuals → direct them to Cherry or Mango (formulas are almost identical to each other, FARNESOL is the only mandatory EU allergen, no photosensitization, no camphor).